Perforated duodenal ulcer: An alternative therapeutic plan

Archives of Surgery

Volumn 133, Issue 11, 1998, Pages 1166-1171

  Donovan, Arthur J ^a   Berne, Thomas V ^a   Donovan, John A ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBON 13; CONTRAST MEDIUM; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; UREA;

ARTICLE; DUODENUM RADIOGRAPHY; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIGHLY SELECTIVE VAGOTOMY; HUMAN; PERITONITIS; PRIORITY JOURNAL; SURGICAL TECHNIQUE; ULCER PERFORATION; ZOLLINGER ELLISON SYNDROME;

EID: 0031771372     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori [editorial]. N Engl J Med. 1993;328:349-350.
2. Gutthann SP, Garcia-Rodriguez LA, Raiford DS. Individual nonsteroidal anti-inflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology. 1997;8:18-24.
3. Hirschowitz BI. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Gastroenterologist. 1994;2:207-223.
4. Ng EK, Chung SC, Sung JJ, et al. High prevalence of Helicobacter pylori infection in duodenal ulcer perforations not caused by non-steroidal anti-inflammatory drugs. Br J Surg. 1996;83:1779-1781.
5. Sebastian M, Chandran VP, Elashaal YI, Sim Al. Helicobacter pylori infection in perforated peptic ulcer disease. Br J Surg. 1995;82:360-362.
6. Tokunaga Y, Hara K, Ryo J, Kitaoka A, Tokuka A, Ohsumi K. Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg. 1998;186:659-663.
7. Holtman G, Tally NJ. Clinical approach to the Helicobacter-infected patient. In: Blaser MJ, Smith PD, Ravdin JI, et al, eds. Infections of the Gastrointestinal Tract. New York, NY: Raven Press; 1985:565-587.
8. Bardhan KD, Wurzer H, Marcelino M, Jahsen J, Lotay N, Roberts PM. Ramtidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. Am J Gastroenterol. 1998;93:380-385.
9. Graham RR. The treatment of perforated duodenal ulcers. Surg Gynecol Obstet. 1937;64:235-238.
10. Lau WY, Leung KH, Kwong KH, et al. A randomized study comparing laparoscopic versus open repair of perforated duodenal ulcer using suture or sutureless technique. Ann Surg. 1996;224:131-138.
11. Berne CJ, Rosoff LR Sr. Acute perforation of peptic ulcer. In: Nyhus LM, Wastell C, eds. Surgery of the Stomach and Duodenum. 3rd ed. Boston, Mass: Little Brown & Co Inc; 1977:441-457.
12. Crisp E. Cases of perforation of the stomach with deductions therefrom relative to the character and treatment of that lesion. Lancet. 1843;2:639.
13. Wangensteen OH. Nonoperative treatment of localized perforations of the duodenum. Minn Med. 1935;18:477-480.
14. Taylor H. Peptic ulcer perforation treated without operation. Lancet. 1946;2:441-444.
15. Seeley SF, Campbell D. Nonoperative treatment of perforated duodenal ulcer: a further report. Surg Gynecol Obstet. 1956;102:435-446.
16. Crofts TJ, Kenneth GM, Park MB, Steele RJC, Chung SSC, Li AKC. A randomized trial of nonoperative treatment for perforated duodenal ulcer. N Engl J Med. 1989; 320:970-973.
17. Berne CJ, Mikkelsen WP. Management of perforated peptic ulcer. Surgery. 1958; 44:591-603.
18. Rosoff LR Sr. Discussion of reference #20. Ann Surg. 1979;189:636.
19. Singer HA, Vaughn RT. Treatment of forme fruste type of perforated peptic ulcer. Surg Gynecol Obstet. 1930;50:10-16.
20. Donovan AJ, Vinson TL, Maulsby GO, Gewin BA. Selective treatment of duodenal ulcer with perforation. Ann Surg. 1979;189:627-636.
21. Li AKC. Response to letter to the editor re: reference #16. N Engl J Med. 1989; 321:1051.
22. Berne TV, Donovan AJ. Nonoperative treatment of perforated duodenal ulcer. Arch Surg. 1989;124:830-832.
23. Boey J, Choi SKI, Poon A, et al. Risk stratification in perforated duodenal ulcers. Ann Surg. 1987;205:22-26.
24. Svanes C, Lie RT, Svanes K, et al. Adverse effects of delayed treatment for perforated peptic ulcer. Ann Surg. 1994;220:168-175.
25. Griffin GE, Organ CH Jr. The natural history of perforated duodenal ulcer treated by suture plication. Ann Surg. 1976;183:382-385.
26. Boey J, Lee NW, Wong J, Ong GB. Perforations in acute duodenal ulcers. Surg Gynecol Obstet. 1982;155:193-196.
27. Jordan GL, Angel RT, Debakey ME. Acute gastroduodenal perforation: comparative study of treatment with simple closure, subtotal gastrectomy and hemigastrectomy and vagotomy. Arch Surg. 1966;92:449-455.
28. Pierandozzi JS, Hinshaw DB, Stafford CE. Vagotomy and pyloroplasty for acute perforated duodenal ulcer: a report of 75 cases. Am J Surg. 1960; 100:245.
29. Jordan PH Jr, Thornby J. Perforated pyloroduodenal ulcers: long term results with omental patch closure and parietal cell vagotomy. Ann Surg. 1995;221:479-486.
30. Sawyers JL, Herrington JL. Perforated duodenal ulcer managed by proximal gastric vagotomy and suture plication. Ann Surg. 1977;185:656-660.
31. Boey J, Branicki DM, Alagaratham TT, et al. Proximal gastric vagotomy: the preferred operation for perforated acute duodenal ulcer. Ann Surg. 1988;208: 169-173.
32. Hermansson M, Stael von Holstein C, Ziling T. Peptic ulcer perforation before and after the introduction of H-2 receptor blockers and proton pump inhibitors. Scand J Gastroenterol. 1977;32:523-529.
33. Macintyre IM, Miller A. Impact of H-2 receptor antagonists on the outcome of treatment of perforated duodenal ulcer. J R Coll Surg Edinb. 1990;35: 348-352.
34. Westblom TU, Laging LM, Midfiff BR, et al. Evaluation of QuickVue, a rapid enzyme immunoassay test for detection of serum antibodies to Helicobacter pylori. Diagn Microbiol Infect Dis. 1993;16:317-320.